Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
Salesforce sign above building entrance
September 2, 2025 4:11 PM 5 min read

Options Corner: Tech's Mixed-Bag Performances Offers A Chance For Salesforce To Storm Ahead

by Josh Enomoto
Follow

ArticleFeaturedTickersList12345!!!

As the go-to name in enterprise cloud computing solutions, Salesforce Inc (NYSE:CRM) plays a pivotal role in modern business networks. Thanks to the digitalization of everything, Salesforce has become the core communications platform for how companies interact with their customers. Further, by embedding artificial intelligence into their software, it took an early lead in the push for automated efficiency. Still, this hasn't always led to strong market performances — which counterintuitively could be a reason to consider CRM stock.

To be sure, Salesforce faces a serious pressure cooker. Ahead of the software giant's fiscal second-quarter earnings disclosure — set to be released tomorrow after the closing bell — the tech sector has conspicuously suffered a mixed-bag performance. Most notably, semiconductor juggernaut Nvidia Corp (NASDAQ:NVDA) stumbled following its earnings report. Despite beating analysts' estimates, data center sales appeared to miss forecasts, leading to the fallout in NVDA stock.

If Salesforce CEO Marc Benioff's words are anything to go by, the company has a chance to distinguish itself from the recently struggling tech sector. In a podcast, Benioff stated that he reduced headcount in the company's customer support division from 9,000 heads to approximately 5,000, all thanks to AI agents.

In other words, while there's legitimate fear that the AI boom is waning, Salesforce appears to be walking the talk — and the upcoming earnings disclosure will be the chance to codify the sentiment.

Using A Cross-Validated Quant Signal To Trade CRM Stock

As exciting as the narrative may be for Salesforce, what really matters is investor demand. In other words, people can say great things about each presidential candidate. But at the end of the day, the vote has to go to a clear winner. From this perspective, CRM stock stands on unusual ground.

In the past 10 weeks, CRM has printed six up weeks, four down weeks, with an overall upward trajectory across the period. For classification purposes, this sequence or quantitative signal can be labeled 6-4-D. It's an unusual pattern as the balance of accumulative sessions outweighs distributive, yet the overall trajectory is negative.

Historically, though, the 6-4-D sequence has generally tended to yield upside performances over the next 10-week period. Following the flashing of the quant signal, the conditional drift has ORCL stock ranging between a median low of $257.23 to a median high of $273.72. In contrast, the aggregate or baseline drift tends to carry the stock between $253.30 and $267.

However, the 6-4-D sequence only stems from in-sample data, which ranges from January 2019 to last Friday's close. To better ensure that we're dealing with actual structure and not just random noise, we must conduct cross validation or out-of-sample tests; that is, analyze how the 6-4-D sequence performs in outside datasets.

To get a more holistic picture, I performed two out-of-sample tests of the 6-4-D sequence, with datasets covering the three years before the COVID-19 crisis and three years after the pandemic:

A detailed analysis would extend well beyond the scope of this article. However, the main takeaway is that in both cases (pre-COVID and post-COVID), the conditional upside pathway is noticeably above the aggregate upside pathway, especially in the later weeks. The main risk-profile difference is in the downside pathway. During the pre-COVID regime, there is a higher danger of volatility if the 6-4-D sequence doesn't yield the desired sentiment reversal.

So, how should investors interpret this data? I would argue that because of the broader integration of AI in the post-COVID regime, the risk profile has been somewhat tempered. Stated differently, in the current regime, the negative pathways have been nominally raised up, thus providing increased confidence for bullish speculators.

Putting Acquired Knowledge Into Practice

Based on the available information — including the out-of-sample tests — the trade that arguably makes the most sense is the 250/260 bull call spread expiring Oct. 17. This transaction involves buying the $250 call and simultaneously selling the $260 call, for a net debit paid of $480 (the most that can be lost in the trade). Should CRM stock rise through the short strike price ($260) at expiration, the maximum profit is $520, a payout of over 108%.

What makes this attractive is that under baseline conditions, the positive drift should take CRM stock above $260 by the Oct. 17 expiration date. Based on the conditional positive drift of the 6-4-D sequence, CRM could potentially go even higher, perhaps around $266.

For the most aggressive trader, betting on the 252.50/257.50 bull spread expiring Sept. 19 wouldn't be out of the question. Here, the net debit required is $245, with a max payout just over 104%. However, the response to tomorrow's earnings report needs to be enthusiastic. Otherwise, there may not be enough time for CRM stock to hit its profitability threshold.

Read More:

  • Options Corner: Identity Security Specialist Okta’s Wild Swings Offer A Quick Flare Pass Opportunity

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
EarningsEquitiesLong IdeasOptionsExpert IdeasOptions Trade of the DayStories That Matter
CRM Logo
CRMSalesforce Inc
$211.61-0.32%
Overview
NVDA Logo
NVDANVIDIA Corp
$190.20-0.49%

For its part, Salesforce is expected to post earnings per share of $2.52 on revenue of $10.13 billion. In the year-ago quarter, the company posted EPS of $2.56 on sales of $9.32 billion. Generally speaking, Salesforce has consistently delivered the goods. Since December 2020, Salesforce hasn't missed on both the top and bottom lines simultaneously. Further, analysts expect a solid outing, with CRM stock carrying a consensus rating of Outperform.

User-generated images
Image by author

The opinions and views expressed in this content are those of the individual author and do not necessarily reflect the views of Benzinga. Benzinga is not responsible for the accuracy or reliability of any information provided herein. This content is for informational purposes only and should not be misconstrued as investment advice or a recommendation to buy or sell any security. Readers are asked not to rely on the opinions or information herein, and encouraged to do their own due diligence before making investing decisions.

CRM Logo
CRMSalesforce Inc
$211.61-0.32%
Overview
NVDA Logo
NVDANVIDIA Corp
$190.20-0.49%
Comments
Loading...